NTRA Natera Inc

Price (delayed)

$114.93

Market cap

$10.78B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.69

Enterprise value

$11.09B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights
Natera's gross profit has surged by 55% YoY and by 12% QoQ
NTRA's revenue is up by 48% year-on-year and by 12% since the previous quarter
Natera's net income has plunged by 105% YoY and by 22% from the previous quarter
The EPS has plunged by 85% YoY and by 18% from the previous quarter

Key stats

What are the main financial stats of NTRA
Market
Shares outstanding
93.78M
Market cap
$10.78B
Enterprise value
$11.09B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
33.79
Price to sales (P/S)
20.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.98
Earnings
Revenue
$504.86M
EBIT
-$301.45M
EBITDA
-$282.3M
Free cash flow
-$280.24M
Per share
EPS
-$3.69
Free cash flow per share
-$3.18
Book value per share
$3.4
Revenue per share
$5.73
TBVPS
$9.65
Balance sheet
Total assets
$849.96M
Total liabilities
$550.85M
Debt
$379.35M
Equity
$299.11M
Working capital
$541.9M
Liquidity
Debt to equity
1.27
Current ratio
3.74
Quick ratio
3.44
Net debt/EBITDA
-1.12
Margins
EBITDA margin
-55.9%
Gross margin
49.6%
Net margin
-62.3%
Operating margin
-61%
Efficiency
Return on assets
-34.5%
Return on equity
-74.3%
Return on invested capital
-31.6%
Return on capital employed
-46.2%
Return on sales
-59.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NTRA stock price

How has the Natera stock price performed over time
Intraday
2.32%
1 week
3.76%
1 month
-8.55%
1 year
60.99%
YTD
15.48%
QTD
3.13%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$504.86M
Gross profit
$250.24M
Operating income
-$308.06M
Net income
-$314.61M
Gross margin
49.6%
Net margin
-62.3%
Natera's operating income has shrunk by 116% YoY and by 26% QoQ
Natera's net income has plunged by 105% YoY and by 22% from the previous quarter
Natera's gross profit has surged by 55% YoY and by 12% QoQ
NTRA's revenue is up by 48% year-on-year and by 12% since the previous quarter

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
33.79
P/S
20.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.98
The EPS has plunged by 85% YoY and by 18% from the previous quarter
The stock's P/B is 59% more than its last 4 quarters average of 21.3 and 6% more than its 5-year quarterly average of 31.9
NTRA's equity is down by 20% since the previous quarter
NTRA's price to sales (P/S) is 151% higher than its 5-year quarterly average of 8.0 and 6% higher than its last 4 quarters average of 19.0
NTRA's revenue is up by 48% year-on-year and by 12% since the previous quarter

Efficiency

How efficient is Natera business performance
The ROS has decreased by 44% YoY and by 10% from the previous quarter
The ROA is down by 26% year-on-year and by 18% since the previous quarter
The ROE has contracted by 22% from the previous quarter and by 12% YoY
The return on invested capital has declined by 16% since the previous quarter and by 13% year-on-year

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total assets is 54% higher than its total liabilities
NTRA's total liabilities is up by 31% year-on-year and by 6% since the previous quarter
The quick ratio has declined by 23% since the previous quarter and by 4.2% year-on-year
The company's debt is 27% higher than its equity
The debt to equity has grown by 43% YoY and by 25% from the previous quarter
The company's debt rose by 40% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.